We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Employment Tribunal decision.
MHRA statement in response to the study in The Lancet on the use of HRT.
Rarely, severe adverse effects can occur on stopping treatment with topical corticosteroids, often after long-term continuous or inappropriate use of moderate to high potency products. To reduce the risks of these events, prescribe the topical corticosteroid of lowest potency needed...
The equality assessment presents the impacts of the introduction of the hormone replacement therapy prescription prepayment certificate (HRT PPC).
First published during the 2022 to 2024 Sunak Conservative government
Consultation on banning conversion therapy, and research reports on the nature, quality and quantity of evidence on its prevalence and practice.
First published during the 2019 to 2022 Johnson Conservative government
Following extensive changes to the formulation and manufacture of levothyroxine tablets by Teva, the Commission on Human Medicines (CHM) is now reassured that Teva has demonstrated an acceptable level of efficacy and safety to allow their levothyroxine tablets to re-enter...
Cases of sexual dysfunction, predominantly involving erectile dysfunction and decreased libido, have been reported rarely in patients taking oral isotretinoin for severe acne.
The CMA investigated certain agreements relating to paroxetine under Chapter I and II of the CA98 and Article 101 of the TFEU.
Women who are current or past users of hormone replacement therapy (HRT) to treat symptoms of the menopause are reminded to be vigilant for signs of breast cancer, even after stopping HRT.
A personal trainer was sentenced today to 31 months in jail for selling and supplying unlicensed and prescription medicines, together with Anabolic steroids, to the public.
Projects include raising awareness of sexual health risks at sex-on-premises venues and vaccinations in non-clinical settings such as pubs and music festivals.
Upper Tribunal Administrative Appeals Chamber decision by Mr Justice Charles, Judge Rowland and Judge Wright on 17 January 2017.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).